Elevated tenascin-C levels in bronchoalveolar lavage fluid of patients with sarcoidosis
- PMID: 22760918
- DOI: 10.1007/s00408-012-9400-1
Elevated tenascin-C levels in bronchoalveolar lavage fluid of patients with sarcoidosis
Abstract
Background: Sarcoidosis is a disease characterized by granulomatous lesions involving multiple organ systems. The etiology of sarcoidosis remains unknown, and reliable biomarkers have not been identified. Tenascin-C is an extracellular matrix molecule expressed during wound healing in various tissues. The present study aimed to investigate the role of tenascin-C in sarcoidosis.
Methods: Enzyme-linked immunosorbent assays were used to measure tenascin-C levels in serum and bronchoalveolar lavage fluid (BALF) from 31 patients with sarcoidosis and 15 healthy individuals. Relationships between tenascin-C concentrations in BALF and serum samples and clinical parameters in patients with sarcoidosis were evaluated.
Results: BALF tenascin-C levels were significantly higher in patients with sarcoidosis than in healthy individuals, but serum levels were no different. BALF tenascin-C levels showed positive correlations with serum lactic dehydrogenase levels and the ratio of lymphocytes in BALF. BALF tenascin-C levels were also higher in patients with parenchymal infiltration on chest radiographs than in those without.
Conclusions: The present results demonstrated that the BALF tenascin-C level was correlated with pulmonary infiltrates on chest radiographs in patients with sarcoidosis. Although measurement of serum tenascin-C levels has a limited role and measurement of BALF tenascin-C levels might be impractical, tenascin-C in the lung might play a role in the pathogenesis of sarcoidosis. Further studies are necessary to determine the role of BALF tenascin-C in sarcoidosis.
Similar articles
-
Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.Eur Respir J. 1997 Dec;10(12):2725-30. doi: 10.1183/09031936.97.10122725. Eur Respir J. 1997. PMID: 9493651 Clinical Trial.
-
MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.Clin Exp Immunol. 2010 Aug;161(2):342-7. doi: 10.1111/j.1365-2249.2010.04181.x. Epub 2010 Jun 9. Clin Exp Immunol. 2010. PMID: 20550547 Free PMC article.
-
Bronchoalveolar lavage fluid D dimer levels are higher and more prevalent in black patients with pulmonary sarcoidosis.Respiration. 2007;74(3):297-303. doi: 10.1159/000091994. Epub 2006 Mar 9. Respiration. 2007. PMID: 16534178
-
Levels of transferrin in bronchoalveolar lavage fluid in sarcoidosis.Lung. 2010 Apr;188(2):151-7. doi: 10.1007/s00408-009-9218-7. Lung. 2010. PMID: 20066543
-
Sarcoidosis: Epidemiology and clinical insights.J Intern Med. 2023 Jun;293(6):668-680. doi: 10.1111/joim.13629. Epub 2023 Mar 14. J Intern Med. 2023. PMID: 36872840 Review.
Cited by
-
Tenascins in fibrotic disorders-from bench to bedside.Cell Adh Migr. 2015;9(1-2):83-9. doi: 10.4161/19336918.2014.994901. Cell Adh Migr. 2015. PMID: 25793575 Free PMC article. Review.
-
Tenascin-C modulates alveolarization in bronchopulmonary dysplasia.Inflamm Regen. 2024 Mar 28;44(1):16. doi: 10.1186/s41232-024-00330-9. Inflamm Regen. 2024. PMID: 38539268 Free PMC article.
-
Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis.Lung. 2014 Aug;192(4):533-42. doi: 10.1007/s00408-014-9586-5. Epub 2014 Apr 29. Lung. 2014. PMID: 24777587
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources